Your browser doesn't support javascript.
loading
Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
Pillet, Sylvie; Jarlot, Camille; Courault, Mathilde; Del Tedesco, Emilie; Chardon, Renaud; Saint-Sardos, Pierre; Presles, Emilie; Phelip, Jean-Marc; Berthelot, Philippe; Pozzetto, Bruno; Roblin, Xavier.
Afiliação
  • Pillet S; *EA-3064, Groupe Immunité des Muqueuses et Agents Pathogènes (GIMAP), Faculty of Medicine of Saint-Etienne, University of Lyon, Lyon, France; †Laboratory of Infectious Agents and Hygiene, University Hospital of Saint-Etienne, France; ‡Department of Gastroenterology, University Hospital of Saint-Etienne, France; and §Inserm, CIE3, F-42055 Saint-Etienne, France.
Inflamm Bowel Dis ; 21(7): 1580-6, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25933392

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ativação Viral / Colite Ulcerativa / Infecções por Citomegalovirus / Citomegalovirus / Infliximab Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ativação Viral / Colite Ulcerativa / Infecções por Citomegalovirus / Citomegalovirus / Infliximab Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article